PharmaShots

APRIL 3, 2023

Meanwhile, Selecta and Sobi reported P-III trial (DISSOLVE I & II) results of SEL-212 for chronic refractory gout Starting with the latest acquisitions, Pfizer acquired Seagen for ~$43B. Shots: The first quarter of 2023 highlights major acquisitions in the pharma and biotech industry along with multiple approvals.

FDA 40

FDA Compounding Hospitals Vaccines 40

Pharmaceutical Technology

AUGUST 3, 2022

The discovery of a new chemical entity (NCE) that could potentially lead the way to a ground-breaking therapeutic treatment is an exciting prospect for any chemist. The potential to use these scientific breakthroughs to make a real difference to patients’ lives is what drives many highly skilled scientists to the world of drug development.

Dosage 52

Dosage 52

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

OCTOBER 27, 2022

Cell and gene therapies are part of advanced therapy medicinal products (ATMPs) and offer great potential for regenerative medicine, including ways to treat and cure a variety of acquired and inherited diseases. This article discusses types of facilities and design considerations for C>. Clinical Trials. Percentage of.

Packaging 52

Packaging Communication Immunization Vaccines 52